Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2021 | Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer | INTERNATIONAL JOURNAL OF CANCER |